MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

D-I03

CAS No. : 688342-78-1

MCE 国际站：D-I03

产品活性：D-I03 是一种选择性 RAD52 抑制剂，K_d 为 25.8 µM。D-I03 抑制 RAD52 依赖性单链退火 (SSA) 和 D 环形成，IC₅₀ 分别为 5 µM 和 8 µM。D-I03 抑制 BRCA1 和 BRCA2 缺陷细胞的生长，并抑制顺铂诱导的 RAD52 病灶形成，但对 RAD51 无影响。

研究领域：Cell Cycle/DNA Damage

作用靶点：DNA/RNA Synthesis

In Vitro: D-I03 (0-10 μM; on days 1 and 3; Capan-1 and UWB1.289 cells) treatment preferentially suppressed the growth of Capan-1 and UWB1.289 cells in a concentration-dependent manner.
D-I03 inhibits RAD52 foci formation induced by cisplatin in BCR-ABL1-positive BRCA1-deficient 32Dcl3 murine hematopoietic cell line that expresses GFP-RAD52. In the presence of D-I03 (2.5 μM), the fraction of cells with RAD52 foci is decreased, from 38.7% to 171%; at the same time, the fraction of Cisplatin-treated cells without foci is increased from 48.4% to 71.9%. D-I03 does not effect on RAD51 foci induced by Cisplatin. Also, D-I03 alone induce neither RAD51 foci nor RAD52 foci (in BRCA1-deficient cells) indicating low genotoxicity of D-I03.

In Vivo: D-I03 (50 mg/kg/day; intraperitoneal injection; daily; for 7 days; nu/nu mice) treatment reduces BRCA1-deficient MDA-MB-436 tumor growth. Talazoparib puls D-I03 does not affect the growth of BRCA1-proficient tumors and does not exert any significant toxicity against normal tissues and organs.
Pharmacokinetic and toxicity studies indicates that maximal tolerated dose of D-I03 is ≥50 mg/kg, and t_1/2 is 23.4 hours, resulting in >1 μM maximal concentration in peripheral blood.

相关产品：Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Anti-Cancer Compound Library  |  Anti-Aging Compound Library  |  Cancer Stem Cells Compound Library  |  Heterocyclic Compound Library  |  Highly Selective Inhibitors Library  |  IBU-DC Phosphoramidite  |  2,4-D sodium salt  |  Thailanstatin D  |  Carboplatin-d₄  |  Caracemide  |  Farudodstat  |  Ara-ATP  |  DNA31  |  2'-OMe-Ac-C Phosphoramidite  |  Dasabuvir  |  DNA Gyrase-IN-4  |  Uridine triphosphate-¹³C₉,¹⁵N₂ sodium  |  5-Methylcytosine  |  Cidofovir dihydrate  |  Capecitabine-d₁₁  |  Tezacitabine  |  Mequindox  |  5-Methylcytosine-d₄  |  TH287 hydrochloride  |  DNA Gyrase-IN-1  |  2'-O-MOE-5-Me-rU  |  Levofloxacin sodium  |  GC7 Sulfate  |  Psammaplin A  |  hDHODH-IN-2  |  Cycloheximide  |  Lurbinectedin-d₃  |  Antipain  |  2'-Deoxy-2'-fluoro-l-uridine  |  (S)-Crizotinib

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

货号: HY-124691

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。